Surv.m-CRA-1

N/A

Report date: 2025/12/09 13:48:50

Base Information

Drug NameSurv.m-CRA-1
Drug Alias NameSurv.m-CRA-1
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionBaculoviral IAP repeat-containing protein 5 inhibitors
TargetsBaculoviral IAP repeat-containing protein 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKagoshima UniversitySurv BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesNippon Zoki Pharmaceutical Co LtdKagoshima UniversityKyoto University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A